The plastic vials and ampoules market is anticipated to expand significantly, with a US$ 5.86 billion total market valuation predicted by 2033. Future Market Insights (FMI) forecast that sales of plastic vials and ampoules are likely to rise at a 6.1% CAGR between 2023 and 2033.
The target market is anticipated to rise significantly, reaching US$ 3.26 billion in 2023. This is due to the market's opportunity being created by the rising demand for protected transport for liquid chemicals and pharmaceuticals. The plastic vials and ampoules industry share is likely to expand due to the increasing acceptance in a number of end-use industries.
| Attributes | Details |
|---|---|
| Plastics Vials and Ampoules Market CAGR (2023 to 2033) | 6.1% |
| Plastics Vials and Ampoules Market Size (2023) | US$ 3.26 billion |
| Plastics Vials and Ampoules Market Size (2033) | US$ 5.86 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Primarily driven by the increasing vaccine production owing to the surging consumption in the healthcare industry across the globe, the plastic vials and ampoules market is anticipated to rise at 6.1% CAGR from 2023 to 2033, in comparison to the 5.2% CAGR registered during 2016 to 2022.
| Particulars | Details |
|---|---|
| Jan - Jun (H1), 2021 (A) | 5.1% |
| Jan - Jun (H1), 2022 Projected (P) | 5.3% |
| Jan - Jun (H1), 2022 Outlook (O) | 5.7% |
| BPS: H1, 2022 (O) - H1,2021 (A) | 60 |
| BPS: H1, 2022 (O) - H1,2021 (A) | 40 |
Plastic vials and ampoules contain certain special grades of plastics, which are made using high density and low-density plastic materials. Plastic vials and ampoules are not only used in hospitals, but also in various other applications, such as personal care & cosmetics, the chemical industry, and homecare products.
As a result, the market shows an excellent growth and increase, from US$ 2.28 billion in 2016 to US$ 3.10 billion in 2022.
The primary demand however comes from the packaging industry, due to increasing demand for the packaging of sterile liquids and different solid and liquid medications, such as powders, tablets, capsules, and antibiotic sterile solutions.
The use of glass material for packaging medication and cosmetics products was common, but the introduction of plastic vials and ampoules offered various benefits over conventional packaging solutions. For instance, they are not only used for dispensing medications or chemical compositions, but also as storage for medicinal and non-medicinal products.
As per the analysis done by Indian Government Commerce, in the fiscal year 2018, the plastic export for rigid packaging from India stood at US$ 315 million at a CAGR of 15.4%. India exported plastics worth US$ 237.1 million in January 2021, and the export from April 2020 to January 2021 was US$ 2.7 billion.
Plastic vials and ampoules are not only used as packaging containers for the controlled medication dispensing, but also for the storage of solid and liquid dosage forms, such as tablets, capsules and powders.
According to the Plastic Packaging Facts Organization, plastic vials and ampoules are used for the testing of newly developed products in clinical research. They also find applications across laboratories for laboratory experiments and storage.
Plastic vials and ampoules make unit dosing or measured dosing easier and more convenient. When compared with the glass vials and ampoules, plastic ones have fewer chances of causing contamination like glass leaching.
Plastic vials and ampoules are preferred for unit drug dosing or fixed drug dosing owing to the ease and convenience in handling. The non-breakable property of plastic is an added advantage that makes it more preferred than glass vials and ampoules.
They are often coated with an amber color that offers exceptional protection from the changing environmental conditions and the excessive sunlight. These properties make plastic vials and ampoules highly desirable as packaging solutions within the healthcare sector.
Principal Consultant
With the increasing awareness about contamination-free dosing, plastic vials and ampoules are gaining significant traction in the pharmaceutical and healthcare industries. These packaging formats are becoming an ideal choice for medicine packaging, as they eliminate the risk of breaking ampoules unlike those made of glass.
If glass particles get mixed into medicines, it can cause serious damage to health if accidentally consumed, or ultimately result in wastage. To avoid such accidents and minimize this risk, most of the drug manufacturing and packaging industries are gradually shifting towards plastic ampoules.
Ongoing research and development activities in the chemical industry are closely related to the development in the pharmaceutical industry. Plastic vials and ampoules are preferred as storage containers used during the research and development activities on a chemical product.
As per Mitsubishi Gas Chemical, plastic vials and ampoules are used to store diluted chemical products, and for the storage of the solid of liquid, low concentrated reagents which need to be added to the container during the research and development activities.
The chemical industry mainly uses the high grade plastic vials and ampoules in the process, owing to the thickness and the material property of the plastic material. Therefore, the demand in the chemical industry is forecast to increase in the coming years, creating attractive prospects for the market’s expansion.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Plastic Vials and Ampoules Market:
| Attributes | Plastic Vials and Ampoules Market |
|---|---|
| CAGR (2023 to 2033) | 6.1% |
| Market Value (2033) | US$ 5.86 billion |
| Growth Factor | Growing need in pharmaceutical sector |
| Opportunity | Demand for sustainable packaging solutions |
| Key Trends | Rising application in end use industries |
Plastic Vials Market:
| Attributes | Plastic Vials Market |
|---|---|
| CAGR (2023 to 2033) | 4.9% |
| Market Value (2033) | US$ 1.99 billion |
| Growth Factor | Development of new drugs and medications |
| Opportunity | Surging applications in the chemical industry |
| Key Trends | Growing demand for vaccination for sustaining immunization power |
Plastic Pails Market:
| Attributes | Plastic Pails Market |
|---|---|
| CAGR (2023 to 2033) | 4.5% |
| Market Value (2033) | US$ 1.9 billion |
| Growth Factor | Rising need of recycled plastic pails among consumers and producers |
| Opportunity | Surge in industrial output |
| Key Trends | New sustainable goals set by manufacturers for packaging solutions |
As per FMI, the United States dominated the market with a share of 20.2% and is worth US$ 627.6 million in 2022. In North America, the United States market is likely to hold a share of 80% during the assessment period.
According to the Organisation for Economic Co-operation and Development, the United States is estimated to remain the most lucrative market for plastic vials and ampoules due to the advancement in the research and development technologies which are propelling the growth of the healthcare sector.
Besides this, the presence of the key operating players supports growth in the country. The United States is also home to some of the world’s leading pharmaceutical companies that are anticipated to excel in the sales of plastic vials and ampoules in the United States.
In the East Asia market, China is expected to create a total incremental revenue opportunity of US$ 386 million by 2033, and estimated to witness a gain of nearly 380 bps of current market share, by 2033.
| Attributes | Statistics |
|---|---|
| China Market Value 2022 | US$ 361.8 million |
| China Market Value 2033 | US$ 722.4 million |
| China Market CAGR (2023 to 2033) | 8% |
Consistently increasing plastic production in the country, along with increasing demand for lightweight and cost effective packaging materials for cosmetics and pharma products, is bolstering sales of plastic vials and ampoules.
According to the Plastics Europe Organization, China contributes to nearly 30% plastic production in the Asia Pacific and is considered as one of the leading countries for manufacturing plastic packaging solutions.
Also, the presence of the key virology research centers in the country is driving the demand for innovations, which is in turn increasing the demand for plastic vials and ampoules market.
In South Asia, India is likely to hold a market share of about 40 to 45% by the end of 2033. The growing packaging industry creates immense growth opportunities for sales of plastic vials and ampoules as packaging solutions for medicinal and non-medicinal products.
| Attributes | Statistics |
|---|---|
| India Market Value 2022 | US$ 270.2 million |
| India Market Value 2033 | US$ 571.6 million |
| India Market CAGR (2023 to 2033) | 8.7% |
According to the India Brand Equity Foundation (IBEF), the Indian packaging industry is expected to reach around US$ 204 Bn in 2025, from US$ 50 Bn in 2019. Currently, the Indian Plastics Industry employs around 4 million people and over 2,000 exporters. Therefore, India is one of the most promising exporters of plastics among developing nations.
Based on the material, COC/COP dominated the market with a share of 44.6 % in 2022. However, the polyethylene plastic vials and ampoules are estimated to hold around 30% of the total market in the forecast period.
The multi variant features of polyethylene, like enhanced protection to the product, excellent rigidity, economical, easy recyclability and durability, are increasing the demand for plastic vials and ampoules made from the material.
Furthermore, the moisture and temperature resistance capacity, along with its lightweight feature, are supplementing the sales of polyethylene plastic vials and ampoules. Polyethylene segment is anticipated to create an incremental opportunity of US$ 591.6 million during the forecast period.
The healthcare segment, followed by the personal care & cosmetics segment, is the leading end user of plastic vials and ampoules. These segments hold a market share of around 40% and 30% respectively in the year 2021.
The hospital segment remains dominant due to the rising demand for plastic vials and ampoules in packaging of sterile liquids or solutions, and use as a container in storing the medication.
Meanwhile, sales in the personal care & cosmetics segment increased by 1.9x times the current market value, by the 2033-year end.
Manufacturers of Plastic Vials and Ampoules Concentrate on New Production Lines to Attract a Larger Network
The key players operating in the plastic vials and ampoules sector are focusing on research and development activities to cater to the increasing demand from various end-use applications. Also, the manufacturers are aiming at strategic partnership and acquisition with other manufacturers to expand their presence.
The market is estimated to secure a valuation of US$ 3.26 billion in 2023.
The global market size to reach US$ 5.86 billion by 2033.
The growth potential of the plastic vials and ampoules market is 6.1% through 2033.
India is projected to emerge as a lucrative market.
Players opt for strategic partnership and acquisition.
1. Executive Summary | Plastic Vials and Ampoules Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Material Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Material Type, 2023 to 2033 5.3.1. Polyethylene 5.3.2. Polypropylene 5.3.3. Polycarbonate 5.3.4. Polyvinyl Chloride 5.3.5. Polystyrene 5.4. Y-o-Y Growth Trend Analysis By Material Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Material Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033 6.3.1. Vials 6.3.2. Ampoules 6.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-Use 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-Use, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-Use, 2023 to 2033 7.3.1. Healthcare 7.3.1.1. Research Laboratories 7.3.1.2. Drug Manufacturing 7.3.1.3. Hospitals and Clinical Research 7.3.2. Personal Care & Cosmetics 7.3.3. Chemical Industry 7.3.4. Homecare Products 7.4. Y-o-Y Growth Trend Analysis By End-Use, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End-Use, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Material Type 9.2.3. By Product Type 9.2.4. By End-Use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Material Type 9.3.3. By Product Type 9.3.4. By End-Use 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Material Type 10.2.3. By Product Type 10.2.4. By End-Use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Material Type 10.3.3. By Product Type 10.3.4. By End-Use 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Material Type 11.2.3. By Product Type 11.2.4. By End-Use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Material Type 11.3.3. By Product Type 11.3.4. By End-Use 11.4. Key Takeaways 12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Singapore 12.2.1.5. Thailand 12.2.1.6. Indonesia 12.2.1.7. Australia 12.2.1.8. New Zealand 12.2.1.9. Rest of Asia Pacific 12.2.2. By Material Type 12.2.3. By Product Type 12.2.4. By End-Use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Material Type 12.3.3. By Product Type 12.3.4. By End-Use 12.4. Key Takeaways 13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Material Type 13.2.3. By Product Type 13.2.4. By End-Use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Material Type 13.3.3. By Product Type 13.3.4. By End-Use 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. USA 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2022 14.1.2.1. By Material Type 14.1.2.2. By Product Type 14.1.2.3. By End-Use 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2022 14.2.2.1. By Material Type 14.2.2.2. By Product Type 14.2.2.3. By End-Use 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2022 14.3.2.1. By Material Type 14.3.2.2. By Product Type 14.3.2.3. By End-Use 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2022 14.4.2.1. By Material Type 14.4.2.2. By Product Type 14.4.2.3. By End-Use 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2022 14.5.2.1. By Material Type 14.5.2.2. By Product Type 14.5.2.3. By End-Use 14.6. United Kingdom 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2022 14.6.2.1. By Material Type 14.6.2.2. By Product Type 14.6.2.3. By End-Use 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2022 14.7.2.1. By Material Type 14.7.2.2. By Product Type 14.7.2.3. By End-Use 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2022 14.8.2.1. By Material Type 14.8.2.2. By Product Type 14.8.2.3. By End-Use 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2022 14.9.2.1. By Material Type 14.9.2.2. By Product Type 14.9.2.3. By End-Use 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2022 14.10.2.1. By Material Type 14.10.2.2. By Product Type 14.10.2.3. By End-Use 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2022 14.11.2.1. By Material Type 14.11.2.2. By Product Type 14.11.2.3. By End-Use 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2022 14.12.2.1. By Material Type 14.12.2.2. By Product Type 14.12.2.3. By End-Use 14.13. Singapore 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2022 14.13.2.1. By Material Type 14.13.2.2. By Product Type 14.13.2.3. By End-Use 14.14. Thailand 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2022 14.14.2.1. By Material Type 14.14.2.2. By Product Type 14.14.2.3. By End-Use 14.15. Indonesia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2022 14.15.2.1. By Material Type 14.15.2.2. By Product Type 14.15.2.3. By End-Use 14.16. Australia 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2022 14.16.2.1. By Material Type 14.16.2.2. By Product Type 14.16.2.3. By End-Use 14.17. New Zealand 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2022 14.17.2.1. By Material Type 14.17.2.2. By Product Type 14.17.2.3. By End-Use 14.18. GCC Countries 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2022 14.18.2.1. By Material Type 14.18.2.2. By Product Type 14.18.2.3. By End-Use 14.19. South Africa 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2022 14.19.2.1. By Material Type 14.19.2.2. By Product Type 14.19.2.3. By End-Use 14.20. Israel 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2022 14.20.2.1. By Material Type 14.20.2.2. By Product Type 14.20.2.3. By End-Use 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Material Type 15.3.3. By Product Type 15.3.4. By End-Use 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Berry Global Inc. 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. West Pharmaceutical Services, Inc. 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Pacific Vial Manufacturing Inc. 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. Aptar Group Inc. 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. Catalent Inc. 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. SiO2 Material Science 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. Shandong Pharmaceutical Glass Co., Ltd. 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. Tonbay Industry Co., Ltd. 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. LA Packaging 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 16.1.10. Thornton Plastics 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 16.1.10.5.3. Channel Strategy 16.1.11. Gerresheimer AG 16.1.11.1. Overview 16.1.11.2. Product Portfolio 16.1.11.3. Profitability by Market Segments 16.1.11.4. Sales Footprint 16.1.11.5. Strategy Overview 16.1.11.5.1. Marketing Strategy 16.1.11.5.2. Product Strategy 16.1.11.5.3. Channel Strategy 16.1.12. Adelphi Healthcare Packaging 16.1.12.1. Overview 16.1.12.2. Product Portfolio 16.1.12.3. Profitability by Market Segments 16.1.12.4. Sales Footprint 16.1.12.5. Strategy Overview 16.1.12.5.1. Marketing Strategy 16.1.12.5.2. Product Strategy 16.1.12.5.3. Channel Strategy 16.1.13. Schott AG 16.1.13.1. Overview 16.1.13.2. Product Portfolio 16.1.13.3. Profitability by Market Segments 16.1.13.4. Sales Footprint 16.1.13.5. Strategy Overview 16.1.13.5.1. Marketing Strategy 16.1.13.5.2. Product Strategy 16.1.13.5.3. Channel Strategy 16.1.14. DWK Life Sciences GmbH 16.1.14.1. Overview 16.1.14.2. Product Portfolio 16.1.14.3. Profitability by Market Segments 16.1.14.4. Sales Footprint 16.1.14.5. Strategy Overview 16.1.14.5.1. Marketing Strategy 16.1.14.5.2. Product Strategy 16.1.14.5.3. Channel Strategy 16.1.15. Amcor Plc 16.1.15.1. Overview 16.1.15.2. Product Portfolio 16.1.15.3. Profitability by Market Segments 16.1.15.4. Sales Footprint 16.1.15.5. Strategy Overview 16.1.15.5.1. Marketing Strategy 16.1.15.5.2. Product Strategy 16.1.15.5.3. Channel Strategy 16.1.16. SGD Pharma 16.1.16.1. Overview 16.1.16.2. Product Portfolio 16.1.16.3. Profitability by Market Segments 16.1.16.4. Sales Footprint 16.1.16.5. Strategy Overview 16.1.16.5.1. Marketing Strategy 16.1.16.5.2. Product Strategy 16.1.16.5.3. Channel Strategy 16.1.17. Stevanato Group 16.1.17.1. Overview 16.1.17.2. Product Portfolio 16.1.17.3. Profitability by Market Segments 16.1.17.4. Sales Footprint 16.1.17.5. Strategy Overview 16.1.17.5.1. Marketing Strategy 16.1.17.5.2. Product Strategy 16.1.17.5.3. Channel Strategy 16.1.18. Origin Pharma Packaging 16.1.18.1. Overview 16.1.18.2. Product Portfolio 16.1.18.3. Profitability by Market Segments 16.1.18.4. Sales Footprint 16.1.18.5. Strategy Overview 16.1.18.5.1. Marketing Strategy 16.1.18.5.2. Product Strategy 16.1.18.5.3. Channel Strategy 16.1.19. Bormioli Pharma S.p.A. 16.1.19.1. Overview 16.1.19.2. Product Portfolio 16.1.19.3. Profitability by Market Segments 16.1.19.4. Sales Footprint 16.1.19.5. Strategy Overview 16.1.19.5.1. Marketing Strategy 16.1.19.5.2. Product Strategy 16.1.19.5.3. Channel Strategy 16.1.20. Nurrin pharmalab pty ltd 16.1.20.1. Overview 16.1.20.2. Product Portfolio 16.1.20.3. Profitability by Market Segments 16.1.20.4. Sales Footprint 16.1.20.5. Strategy Overview 16.1.20.5.1. Marketing Strategy 16.1.20.5.2. Product Strategy 16.1.20.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Packaging Insights
View Reports
Plastic Vials and Ampoules Market
